bvac-c
Biologicalexperimental
Clinical trial activity
3 trials · 6 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Oct 1, 2016 (NCT02866006)
Timeline
Indications
Mechanism of action
- Human papillomavirusImmunity, active
Human papillomavirus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- bvac-c
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06797986 | Phase 1/Phase 2 (Phase 2) | Mar 31, 2025 | Cellid Co., Ltd. |
| NCT04800978 | Phase 2 | Jun 14, 2021 | National Cancer Center, Korea, Seoul National University, Sungkyunkwan University, University of Ulsan, Yonsei University |
| NCT02866006 | Phase 1 | Oct 1, 2016 | Cellid Co., Ltd., Seoul National University |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (6)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Cellid Co., Ltd. | For profit | 2 | 2 | 2 | 2016 |
| Seoul National University | Academic/Hospital | 2 | 0 | 2 | 2016 |
| National Cancer Center, Korea | Government | 1 | 0 | 1 | 2021 |
| Sungkyunkwan University | Academic/Hospital | 1 | 1 | 1 | 2021 |
| University of Ulsan | Academic/Hospital | 1 | 0 | 1 | 2021 |
| Yonsei University | Academic/Hospital | 1 | 0 | 1 | 2021 |
6 organizations
Page 1 / 1